MADRIGAL PHARMACEUTICALS, INC. (MDGL) Capital expenditures 2016–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$467,000FY2025 · since FY2016: $3,000 → $467,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $467,000 | -68.1% |
| FY2024 | $1.5M | -1.1% |
| FY2023 | $1.5M | +581.6% |
| FY2022 | $217,000 | +3.8% |
| FY2021 | $209,000 | -37.4% |
| FY2020 | $334,000 | +94.2% |
| FY2019 | $172,000 | +681.8% |
| FY2018 | $22,000 | -82.4% |
| FY2017 | $125,000 | +4066.7% |
| FY2016 | $3,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice